6 completed. 4 Not applicable, 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Completed 4 |
| Phase 4 | 2 | Completed 2 |
Follow AiCure: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Youth Ending the HIV Epidemic aDOT-CEI - HIV/AIDS, Mobile Health | Not applicable | Completed | University of California, San Francisco | 28 | 2023-01-31 | 2024-08-26 |
| DOT Diary Mobile App for Pre-Exposure Prophylaxis Adherence in Young Men Emtricitabine / Tenofovir Disoproxil Oral Tablet, DOT Diary mobile app - Adherence, Medication, Risk Behavior | Phase 4 | Completed | Public Health Foundation Enterprises, Inc. | 100 | 2019-02-01 | 2025-07-03 |
| DOT Diary Optimization Pilot: A Pilot Study to Optimize the DOT Diary App to Measure PrEP Adherence Emtricitabine / Tenofovir Disoproxil Oral Tablet, DOT Diary mobile app - Adherence, Medication, Risk Behavior | Phase 4 | Completed | Public Health Foundation Enterprises, Inc. | 20 | 2018-02-28 | 2021-10-27 |
| Smartphone Based aDOT Treatment With Fixed-Dose Elbasvir and Grazoprevir in PWIDs AiCure, AiCure with gamification - Hepatitis C, Medication Adherence | Not applicable | Completed | Albert Einstein College of Medicine | 11 | 2017-11-14 | 2021-09-14 |
| Using Artificial Intelligence To Monitor Medication Adherence in Opioid Replacement Therapy AiCure monitoring and intervention - Opiate Addiction, Medication Non-adherence | Not applicable | Completed | AiCure | 9 | 2016-08-01 | 2017-09-12 |
| Using Artificial Intelligence to Measure and Optimize Adherence in Patients on Anticoagulation Therapy. Monitored (M+) - Stroke | Not applicable | Completed | AiCure | 28 | 2015-03-01 | 2016-07-12 |
Medication Adherence (4) · Directly Observed Therapy (3) · Behavior, Addictive (2) · Patient Compliance (2) · Risk-Taking (2) · Acquired Immunodeficiency Syndrome (1) · Hepatitis C (1) · Hepatitis C, Chronic (1) · Liver Diseases (1) · Opioid-Related Disorders (1) · Reinfection (1) · Stroke (1)
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (2) · Methods (1)
United States (6)
Susan Buchbinder, MD (2) · Adam Hanina, MBA (1) · Adam Hanina, MBA, MPhil (1) · Alain Litwin, MD (1) · Daniel Labovitz, MD (1) · Julia Arnsten, MD (1) · Parya Saberi, PharmD (1)
PMID 28386037, PMID 33044687, PMID 38134037, PMID 39222964
R01MH109320 (2), P30MH062246 (1)